Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 12, 2011
The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiationT Yamamoto, K Nakai, T Nariai, et al.
Hepatology (Baltimore, Md.)|March 1, 1997
Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infectionK Chayama, A Tsubota, M Kobayashi, et al.
Journal of Viral Hepatitis|October 3, 2014
Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patientsT Hara, F Suzuki, Y Kawamura, et al.
Journal of Viral Hepatitis|May 1, 2004
Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infectionF Suzuki, Y Arase, Y Suzuki, et al.
The Journal of General Virology|March 26, 1999
Susceptibility of TT virus to interferon therapyK Chayama, M Kobayashi, A Tsubota, et al.
Journal of Gastroenterology and Hepatology|September 15, 1998
Biochemical and histological features of hepatitis G virus infectionM Kobayashi, K Chayama, M Fukuda, et al.
Journal of Gastroenterology|May 30, 1998
Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotypeM Kobayashi, H Kumada, Y Arase, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 14, 2011
Boron neutron capture therapy combined with fractionated photon irradiation for glioblastoma: a recursive partitioning analysis of BNCT patientsK Nakai, T Yamamoto, H Aiyama, et al.
ESMO Open|May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinomaR S Finn, M Kudo, P Merle, et al.
Pageof 15